Comparing the Incidence of Preeclampsia Between Pregnant Women Receiving Tdap Vaccinations at Week 28 or at Week 36

Clinical trial NCT04424693 · UNKNOWN

Trial details

NCT number: NCT04424693
Sponsor: Institute of Arthritis Research
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Pre-Eclampsia Diphtheria, Tetanus and Pertussis Vaccine Reaction

Start date: 2020-12-01
Primary completion: 2023-10-01
Enrollment: 1600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.